Delcath Systems, Inc. insider trading
Every open-market purchase and sale by Delcath Systems, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Delcath Systems, Inc.’s insiders pay?
From June 4, 2012 to March 6, 2026, 20 insiders reported 63 open-market purchases and 0 sales not made under a pre-set plan in Delcath Systems, Inc. Twelve months after each purchase was reported, the shares were −35.1% against the S&P 500 on average (median −45.4%), over 31 purchases with a full year of prices; 10% beat the index. Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on November 16, 2020 into $12,916 by November 2, 2026, +4.4% a year. It held shares 79% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $19,618 (+12.0% a year), and held throughout $22,622 (+14.7%).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Salamon Steven A J | Director | 13 | −37.1% (9) | 0% | 0 | — | March 20, 2024 |
| Michel Gerard J | CHIEF EXECUTIVE OFFICER | 12 | −43.6% (7) | 0% | 0 | — | March 3, 2026 |
| Rosalind Advisors, Inc. | Director | 11 | −32.9% (9) | 11% | 0 | — | November 21, 2023 |
| Purpura John | Chief Operating Officer | 5 | −46.1% (3) | 0% | 0 | — | October 17, 2023 |
| Aharon Gil | Director | 3 | −24.9% (2) | 50% | 0 | — | March 20, 2024 |
| Pennell Sandra | Chief Financial Officer | 2 | — | — | 0 | — | March 6, 2026 |
| Philips Laura A | Director | 2 | — | — | 0 | — | July 24, 2015 |
| Sylvester John Richard | Director | 2 | +36.0% (1) | 100% | 0 | — | November 25, 2025 |
| Vukovic Vojo | Chief Medical Officer | 2 | — | — | 0 | — | December 14, 2023 |
| Hobbs Eamonn P | President and CEO | 1 | — | — | 0 | — | June 4, 2012 |
| Hoffman David L. | See Remarks | 1 | — | — | 0 | — | November 20, 2023 |
| Keck Barbra | Chief Financial Officer | 1 | — | — | 0 | — | October 23, 2018 |
| Koplewicz Harold S | Director | 1 | — | — | 0 | — | June 4, 2012 |
| Leung Gabriel | Director | 1 | — | — | 0 | — | June 18, 2012 |
| Miao Graham G | Exec. V.P., CFO | 1 | — | — | 0 | — | June 4, 2012 |
| Rueckert William Dodge | Director | 1 | — | — | 0 | — | October 23, 2018 |
| Simpson Jennifer K. | President & CEO | 1 | — | — | 0 | — | October 23, 2018 |
| Stoll Roger G Phd | Director | 1 | — | — | 0 | — | July 28, 2015 |
| Taglietti Marco | Director | 1 | — | — | 0 | — | July 28, 2015 |
| Watson Douglas G | Director | 1 | — | — | 0 | — | June 4, 2012 |
When several insiders traded Delcath Systems, Inc.
Months when 2 or more insiders became net buyers, or 3 or more net sellers, of Delcath Systems, Inc. in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After the 5 buying crowds with six months of prices, it averaged −9.2% against the index. One company's history is too short to judge by; the test across every company is the better guide.
| Month | Crowd | 3 months on, vs S&P 500 | 6 months | 12 months |
|---|---|---|---|---|
| March 31, 2026 | 2 buying | +24.1% | +54.2% | not yet |
| November 28, 2025 | 2 buying | −11.2% | −3.2% | not yet |
| January 31, 2022 | 3 buying | −7.6% | −27.2% | −39.0% |
| May 28, 2021 | 2 buying | −21.2% | −18.9% | −57.5% |
| November 30, 2020 | 4 buying | +10.6% | −50.7% | −68.3% |